BNIGF OTC
Beroni Group Limited
1W: +0.0%
1M: +0.0%
3M: +0.0%
YTD: +0.0%
1Y: +0.0%
3Y: -99.9%
5Y: -99.2%
$0.01
+0.00 (+0.00%)
Overview
Chart
Smart Money
Financials
Income Statement
Cash Flow
Balance Sheet
Earnings
Analysis
Technicals
Weather
Peers
ESG
Institutions
Dark Pool
Short Interest
Smart Money Score
No convergence signal
Key Statistics
Market Cap$0.2M
52W Range0.0021-0.0064
Volume27
Avg Volume23
Beta-1.76
Dividend—
Analyst Ratings
No analyst coverage
Company Info
CEOBoqing Zhang
Employees5
SectorHealthcare
IndustryBiotechnology
IPO Date2019-08-27
Websiteberonigroup.com
Gateway
Sydney, NSW 2000
AU
Sydney, NSW 2000
AU
61 2 9283 4808
About Beroni Group Limited
Beroni Group is an international biopharmaceutical enterprise dedicated to the innovation and commercialization of drugs and therapies to combat various global diseases such as cancer and infectious diseases. Its diversified portfolio is comprised of FDA/CE approved virus diagnostic kits, an e-commerce platform for the sale of pharmaceutical products, and a development pipeline targeting oncology and cell therapies. The company has operations in Australia, the United States, China, and Japan.
Latest News
No recent news
Recent Insider Trades
No insider trades found